Emerging Opportunities in the Non-specific Endonucleases Market

bir ses eklendi Literature

2026-10-13 12:17:52 -

The Non-specific Endonucleases Market is diversifying as advanced therapies and outsourced manufacturing gain share. Valued at USD 353.60 million in 2024, the market is projected to reach USD 374.98 million in 2025 and USD 641.80 million by 2034, growing at a CAGR of 6.15% during the forecast period 2025–2034. Demand from cell and gene therapy, contract development and manufacturing, and...

0 Yorumlar 0 hisse senetleri 72 Views 0 önizleme